{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:26:17Z","timestamp":1788269177504,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302914"],"award-info":[{"award-number":["82302914"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10120-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T03:33:23Z","timestamp":1767756803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FTO-mediated m6A demethylation of CSF3 suppresses NETosis via downregulation of RLN2 expression in colorectal cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Junfeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"10120_CR1","doi-asserted-by":"publisher","first-page":"1366223","DOI":"10.3389\/fonc.2024.1366223","volume":"14","author":"S Alam","year":"2024","unstructured":"Alam S, Giri PK. Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects. Front Oncol. 2024;14:1366223. https:\/\/doi.org\/10.3389\/fonc.2024.1366223.","journal-title":"Front Oncol"},{"key":"10120_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol Cancer"},{"key":"10120_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.semcancer.2021.04.007","volume":"84","author":"P Andrei","year":"2022","unstructured":"Andrei P, Battuello P, Grasso G, Rovera E, Tesio N, Bardelli A. Integrated approaches for precision oncology in colorectal cancer: the more you know, the better. Semin Cancer Biol. 2022;84:199\u2013213. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.007.","journal-title":"Semin Cancer Biol"},{"key":"10120_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/life11080731","author":"J Bialek","year":"2021","unstructured":"Bialek J, Piwonka M, Kawan F, Fornara P, Theil G. Differential expression of the androgen receptor, splice variants and relaxin 2 in renal cancer. Life (Basel, Switzerland). 2021. https:\/\/doi.org\/10.3390\/life11080731.","journal-title":"Life (Basel, Switzerland)"},{"key":"10120_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"10120_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370. https:\/\/doi.org\/10.1002\/hep.29683.","journal-title":"Hepatology"},{"key":"10120_CR7","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1007\/s00018-014-1683-3","volume":"71","author":"J Cools-Lartigue","year":"2014","unstructured":"Cools-Lartigue J, Spicer J, Najmeh S, Ferri LJC, Cmls MLS. Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci. 2014;71:4179\u201394.","journal-title":"Cell Mol Life Sci"},{"key":"10120_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41467-023-44576-2","volume":"15","author":"W Dai","year":"2024","unstructured":"Dai W, Tian R, Yu L, Bian S, Chen Y, Yin B, et al. Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma. Nat Commun. 2024;15:131. https:\/\/doi.org\/10.1038\/s41467-023-44576-2.","journal-title":"Nat Commun"},{"key":"10120_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082438","author":"M Fue","year":"2018","unstructured":"Fue M, Miki Y, Takagi K, Hashimoto C, Yaegashi N, Suzuki T, et al. Relaxin 2\/RXFP1 signaling induces cell invasion via the \u03b2-catenin pathway in endometrial cancer. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19082438.","journal-title":"Int J Mol Sci"},{"key":"10120_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16:361\u201375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10120_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/17446651.2020.1730176","volume":"15","author":"M Gholamalizadeh","year":"2020","unstructured":"Gholamalizadeh M, Jarrahi AM, Akbari ME, Bourbour F, Mokhtari Z, Salahshoornezhad S, et al. Association between FTO gene polymorphisms and breast cancer: the role of estrogen. Expert Rev Endocrinol Metab. 2020;15:115\u201321. https:\/\/doi.org\/10.1080\/17446651.2020.1730176.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10120_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1159\/000491915","volume":"48","author":"Y He","year":"2018","unstructured":"He Y, Hu H, Wang Y, Yuan H, Lu Z, Wu P, et al. ALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylation. Cell Physiol Biochem. 2018;48:838\u201346. https:\/\/doi.org\/10.1159\/000491915.","journal-title":"Cell Physiol Biochem"},{"key":"10120_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. M(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270\u201388. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.004.","journal-title":"Cancer Cell"},{"key":"10120_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s1043-2760(02)00664-1","volume":"13","author":"R Ivell","year":"2002","unstructured":"Ivell R, Einspanier A. Relaxin peptides are new global players. Trends Endocrinol Metab. 2002;13:343\u20138. https:\/\/doi.org\/10.1016\/s1043-2760(02)00664-1.","journal-title":"Trends Endocrinol Metab"},{"key":"10120_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116323","volume":"225","author":"A Kotwal","year":"2024","unstructured":"Kotwal A, Simpson R, Whiteman N, Swanson B, Yuil-Valdes A, Fitch M, et al. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans. Biochem Pharmacol. 2024;225:116323. https:\/\/doi.org\/10.1016\/j.bcp.2024.116323.","journal-title":"Biochem Pharmacol"},{"key":"10120_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03689-3","volume":"73","author":"Q Lei","year":"2024","unstructured":"Lei Q, Zhen S, Zhang L, Zhao Q, Yang L, Zhang Y. A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. Cancer Immunol Immunother. 2024;73:108. https:\/\/doi.org\/10.1007\/s00262-024-03689-3.","journal-title":"Cancer Immunol Immunother"},{"key":"10120_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, et al. Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types. Mol Cancer. 2019;18:137. https:\/\/doi.org\/10.1186\/s12943-019-1066-3.","journal-title":"Mol Cancer"},{"key":"10120_CR18","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.24","volume":"7","author":"Y Liang","year":"2024","unstructured":"Liang Y, Wu G, Tan J, Xiao X, Yang L, Saw PE. Targeting NETosis: nature\u2019s alarm system in cancer progression. Cancer Drug Resistance (Alhambra, Calif). 2024;7:28. https:\/\/doi.org\/10.20517\/cdr.2024.24.","journal-title":"Cancer Drug Resistance (Alhambra, Calif)"},{"key":"10120_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41575-023-00884-y","volume":"21","author":"S Lin","year":"2024","unstructured":"Lin S, Kuang M. RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2024;21:267\u201381. https:\/\/doi.org\/10.1038\/s41575-023-00884-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10120_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K, et al. M(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20:1074\u201383. https:\/\/doi.org\/10.1038\/s41556-018-0174-4.","journal-title":"Nat Cell Biol"},{"key":"10120_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-022-04950-2","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, He H, Zhang F, Hu X, Bi F, Li K, et al. M6A methylated EphA2 and VEGFA through IGF2BP2\/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K\/AKT and ERK1\/2 signaling. Cell Death Dis. 2022;13:483. https:\/\/doi.org\/10.1038\/s41419-022-04950-2.","journal-title":"Cell Death Dis"},{"key":"10120_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11:519\u201331. https:\/\/doi.org\/10.1038\/nri3024.","journal-title":"Nat Rev Immunol"},{"key":"10120_CR23","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/1078-0432.Ccr-24-1363","volume":"30","author":"YM Mowery","year":"2024","unstructured":"Mowery YM, Luke JJ. NETosis impact on tumor biology, radiation, and systemic therapy resistance. Clin Cancer Res. 2024;30:3965\u20137. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-24-1363.","journal-title":"Clin Cancer Res"},{"issue":"S3","key":"10120_CR24","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.21037\/cdt.2017.08.01","volume":"7","author":"R Oklu","year":"2017","unstructured":"Oklu R, Sheth RA, Wong KHK, Jahromi AH, Albadawi H. Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis. Cardiovasc Diagn Ther. 2017;7(S3):S140\u20139. https:\/\/doi.org\/10.21037\/cdt.2017.08.01.","journal-title":"Cardiovasc Diagn Ther"},{"key":"10120_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134\u201347. https:\/\/doi.org\/10.1038\/nri.2017.105.","journal-title":"Nat Rev Immunol"},{"key":"10120_CR26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/bph.13684","volume":"174","author":"NA Patil","year":"2017","unstructured":"Patil NA, Rosengren KJ, Separovic F, Wade JD, Bathgate RAD, Hossain MA. Relaxin family peptides: structure-activity relationship studies. Br J Pharmacol. 2017;174:950\u201361. https:\/\/doi.org\/10.1111\/bph.13684.","journal-title":"Br J Pharmacol"},{"key":"10120_CR27","first-page":"1030","volume":"19","author":"XF Ren","year":"2015","unstructured":"Ren XF, Zhao H, Gong XC, Wang LN, Ma JF. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4\/MMP-9 signal. Eur Rev Med Pharmacol Sci. 2015;19:1030\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10120_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","volume":"571","author":"RJ Ries","year":"2019","unstructured":"Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, et al. M(6)A enhances the phase separation potential of mRNA. Nature. 2019;571:424\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1374-1.","journal-title":"Nature"},{"key":"10120_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367. https:\/\/doi.org\/10.1038\/s41577-021-00534-x.","journal-title":"Nat Rev Immunol"},{"key":"10120_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jleuko\/qiad004","volume":"113","author":"Y Sheng","year":"2023","unstructured":"Sheng Y, Peng W, Huang Y, Cheng L, Meng Y, Kwantwi LB, et al. Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis. J Leukoc Biol. 2023;113:383\u201399. https:\/\/doi.org\/10.1093\/jleuko\/qiad004.","journal-title":"J Leukoc Biol"},{"key":"10120_CR31","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/0008-5472.Can-23-1954","volume":"84","author":"F Shu","year":"2024","unstructured":"Shu F, Liu H, Chen X, Liu Y, Zhou J, Tang L, et al. M6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB. Cancer Res. 2024;84:1947\u201362. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-1954.","journal-title":"Cancer Res"},{"key":"10120_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"10120_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.mce.2015.10.011","volume":"420","author":"G Tevz","year":"2016","unstructured":"Tevz G, McGrath S, Demeter R, Magrini V, Jeet V, Rockstroh A, et al. Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer. Mol Cell Endocrinol. 2016;420:159\u201368. https:\/\/doi.org\/10.1016\/j.mce.2015.10.011.","journal-title":"Mol Cell Endocrinol"},{"key":"10120_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1158\/2159-8290.Cd-18-0959","volume":"9","author":"LP Vu","year":"2019","unstructured":"Vu LP, Cheng Y, Kharas MG. The biology of m(6)A RNA methylation in normal and malignant hematopoiesis. Cancer Discov. 2019;9:25\u201333. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-0959.","journal-title":"Cancer Discov"},{"key":"10120_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320. https:\/\/doi.org\/10.1038\/nature12730.","journal-title":"Nature"},{"key":"10120_CR36","doi-asserted-by":"publisher","first-page":"2306674","DOI":"10.1080\/15384047.2024.2306674","volume":"25","author":"YY Wang","year":"2024","unstructured":"Wang YY, Ye LH, Zhao AQ, Gao WR, Dai N, Yin Y, et al. M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells. Cancer Biol Ther. 2024;25:2306674. https:\/\/doi.org\/10.1080\/15384047.2024.2306674.","journal-title":"Cancer Biol Ther"},{"key":"10120_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102310","volume":"53","author":"J Xu","year":"2025","unstructured":"Xu J, Li N, Xie H, Duan C, Liao X, Li R, et al. CSF3 promotes colorectal cancer progression by activating p65\/NF-\u03baB signaling pathway and inducing an immunosuppressive microenvironment. Transl Oncol. 2025;53:102310. https:\/\/doi.org\/10.1016\/j.tranon.2025.102310.","journal-title":"Transl Oncol"},{"key":"10120_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang L, Liu Q, Zhang X, Liu X, Zhou B, Chen J, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583:133\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2394-6.","journal-title":"Nature"},{"key":"10120_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102297","volume":"97","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yu S, Lv C, Tian Y. NETosis in tumour microenvironment of liver: from primary to metastatic hepatic carcinoma. Ageing Res Rev. 2024;97:102297. https:\/\/doi.org\/10.1016\/j.arr.2024.102297.","journal-title":"Ageing Res Rev"},{"key":"10120_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13578-023-01100-9","volume":"13","author":"M Ye","year":"2023","unstructured":"Ye M, Chen J, Lu F, Zhao M, Wu S, Hu C, et al. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer. Cell Biosci. 2023;13:148. https:\/\/doi.org\/10.1186\/s13578-023-01100-9.","journal-title":"Cell Biosci"},{"key":"10120_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature23883","volume":"549","author":"C Zhang","year":"2017","unstructured":"Zhang C, Chen Y, Sun B, Wang L, Yang Y, Ma D, et al. M(6)A modulates haematopoietic stem and progenitor cell specification. Nature. 2017;549:273\u20136. https:\/\/doi.org\/10.1038\/nature23883.","journal-title":"Nature"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10120-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T03:33:26Z","timestamp":1767756806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10120"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10120-9","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research procedures associated with mice were approved by the Experimental Animal Ethics Committee of Yangzhou University (Ethics No. 202409049).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}